{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:57:10Z","timestamp":1781071030976,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72274045"],"award-info":[{"award-number":["72274045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.diabres.2025.112965","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:44:51Z","timestamp":1761810291000},"page":"112965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Health state utility values for patients with type 2 diabetes in China: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"230","author":[{"given":"Xu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112965_b0005","unstructured":"Organization WH. Diagnosis and Management of Type 2 Diabetes. WHO. 2020."},{"key":"10.1016\/j.diabres.2025.112965_b0010","unstructured":"Organization WH. HEARTS D: diagnosis and management of type 2 diabetes. WHO. 2020."},{"key":"10.1016\/j.diabres.2025.112965_b0015","unstructured":"Federation ID. IDF Diabetes Atlas 10th edition. IDF. 2020."},{"key":"10.1016\/j.diabres.2025.112965_b0020","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2337\/dc14-0574","article-title":"The SEARCH for Diabetes in Youth study: rationale, findings, and future directions","volume":"37","author":"Hamman","year":"2014","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabres.2025.112965_b0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14737167.2019.1661777","article-title":"Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus","volume":"20","author":"Duan","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"10.1016\/j.diabres.2025.112965_b0030","first-page":"819","article-title":"Study on prevalence rates of hypertension and chronic diabetic complications of in-patients with diabetes","volume":"24","author":"Xiang","year":"2003","journal-title":"Chin J Epidemiol"},{"key":"10.1016\/j.diabres.2025.112965_b0035","article-title":"Trends in economic burden of type 2 diabetes in China: based on longitudinal claim data","volume":"11","author":"Liu","year":"2023","journal-title":"Front Public Health."},{"key":"10.1016\/j.diabres.2025.112965_b0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12889-019-6569-8","article-title":"Complications of diabetes in China: health system and economic implications","volume":"19","author":"Mao","year":"2019","journal-title":"BMC Public Health."},{"key":"10.1016\/j.diabres.2025.112965_b0045","first-page":"859","article-title":"Cost-utility analysis","volume":"307","author":"Robinson","year":"1993","journal-title":"Econ Eval Health Care"},{"key":"10.1016\/j.diabres.2025.112965_b0050","doi-asserted-by":"crossref","unstructured":"Brazier J, Ratcliffe J, Saloman J, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation: Oxford University Press. 2016. doi: 10.1093\/med\/9780198725923.001.0001.","DOI":"10.1093\/med\/9780198725923.001.0001"},{"key":"10.1016\/j.diabres.2025.112965_b0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0021-9681(87)90019-1","article-title":"Utility approach to measuring health-related quality of life","volume":"40","author":"Torrance","year":"1987","journal-title":"J Chronic Dis."},{"key":"10.1016\/j.diabres.2025.112965_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12955-024-02288-1","article-title":"Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression","volume":"22","author":"Wang","year":"2024","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.diabres.2025.112965_b0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jval.2020.12.019","article-title":"Health state utility values for Type 2 diabetes and related complications in east and southeast Asia: A systematic review and meta-analysis","volume":"24","author":"Mok","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.diabres.2025.112965_b0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vhri.2022.09.005","article-title":"Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-analysis","volume":"34","author":"Redenz","year":"2023","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.diabres.2025.112965_b0075","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s13300-024-01606-6","article-title":"Epidemiology and burden of peripheral artery disease in people with type 2 diabetes: a systematic literature review","volume":"15","author":"Verma","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2025.112965_b0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11136-019-02292-9","article-title":"Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China","volume":"29","author":"Hao","year":"2020","journal-title":"Qual Life Res"},{"key":"10.1016\/j.diabres.2025.112965_b0085","doi-asserted-by":"crossref","unstructured":"Jin X, Liu GG, Gerstein HC, Levine MAH, Guan H, Li H, et al. Minimally important difference and predictors of change in quality of life in type 2 diabetes: a community-based survey in China. Diabetes Metab Res Rev 2018;34:e3053. doi: 10.1002\/dmrr.3053.","DOI":"10.1002\/dmrr.3053"},{"key":"10.1016\/j.diabres.2025.112965_b0090","doi-asserted-by":"crossref","unstructured":"Gu S, Wang X, Shi L, Sun Q, Hu X, Gu Y, et al. Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Qual Life Res 2020;29:2695\u2013704. doi: 10.1007\/s11136-020-02524-3.","DOI":"10.1007\/s11136-020-02524-3"},{"key":"10.1016\/j.diabres.2025.112965_b0095","first-page":"1091","article-title":"Health state utility values for diabetes patients in China: a systematic review and meta-analysis","volume":"49","author":"Shi","year":"2022","journal-title":"Modern Preventive Med"},{"key":"10.1016\/j.diabres.2025.112965_b0100","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71. doi: 10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"10.1016\/j.diabres.2025.112965_b0105","doi-asserted-by":"crossref","unstructured":"Muchadeyi MT, Hernandez-Villafuerte K, Schlander M. Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis. BMC Med Res Methodol 2022;22:303. doi: 10.1186\/s12874-022-01784-6.","DOI":"10.1186\/s12874-022-01784-6"},{"key":"10.1016\/j.diabres.2025.112965_b0110","doi-asserted-by":"crossref","unstructured":"Nerich V, Saing S, Gamper EM, Holzner B, Pivot X, Viney R, et al. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses. Breast Cancer Res Treat 2017;164:527\u201336. doi: 10.1007\/s10549-017-4283-8.","DOI":"10.1007\/s10549-017-4283-8"},{"key":"10.1016\/j.diabres.2025.112965_b0115","doi-asserted-by":"crossref","unstructured":"Zoratti MJ, Pickard AS, Stalmeier PFM, Ollendorf D, Lloyd A, Chan KKW, et al. Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists. Eur J Health Econ. 2021;22:723-33. doi: 10.1007\/s10198-021-01286-0.","DOI":"10.1007\/s10198-021-01286-0"},{"key":"10.1016\/j.diabres.2025.112965_b0120","unstructured":"Wei XM, Zhang YG, Tao H, Tang HM, Chen H, Zeng XT. How to perform meta-analysis of correlation coefficients using meta package and metafor package in R. Chin J Evid-based Med. 2015;15:850\u201360. doi: 10.7507\/1672-2531.20150144."},{"key":"10.1016\/j.diabres.2025.112965_b0125","first-page":"229","article-title":"Association between side efects of oral anti\u2014diabetic drugs and self-reported mental health and quality of life among patients with type 2 diabetes","volume":"91","author":"Chen","year":"2011","journal-title":"Natl Med J China"},{"key":"10.1016\/j.diabres.2025.112965_b0130","doi-asserted-by":"crossref","unstructured":"Yang W, Zhuang X, Li Y, Wang Q, Bian R, Shen J, et al. Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve\u00ae observational study. Health Qual Life Outcomes 2014;12:137. doi: 10.1186\/s12955-014-0137-9.","DOI":"10.1186\/s12955-014-0137-9"},{"key":"10.1016\/j.diabres.2025.112965_b0135","doi-asserted-by":"crossref","unstructured":"Ji L, Zou D, Liu L, Qian L, Kadziola Z, Babineaux S, et al. Increasing body mass index identifies Chinese patients with type 2 diabetes mellitus at risk of poor outcomes. J Diabetes Complications. 2015;29:488\u201396. doi: 10.1016\/j.jdiacomp.2015.02.014.","DOI":"10.1016\/j.jdiacomp.2015.02.014"},{"key":"10.1016\/j.diabres.2025.112965_b0140","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wu J, Chen Y, Shi L. EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China. Diabetes Ther. 2020;11:939\u201350. doi: 10.1007\/s13300-020-00788-z.","DOI":"10.1007\/s13300-020-00788-z"},{"key":"10.1016\/j.diabres.2025.112965_b0145","unstructured":"Li X, Xu ZR, Wang AH, Niu WF, Li LJ, Mu YM, et al. Quality of Life and Affecting Factors in Elderly Patients with Type 2 Diabetes in Chinese Tertiary Hospitals. Chin J Mult Organ Dis Elderly. 2020;19:845\u201350. doi: 10.11915\/j.issn.1671-5403.2020.11.195."},{"key":"10.1016\/j.diabres.2025.112965_b0150","unstructured":"Li X, Xu ZR, Niu WF, LI LJ, Mu YM, Lu ZQ. Evaluation of the relationship between treatment regimens and quality of life in patients with type 2 diabetes. Chin J Diabetes. 2020;28:29\u201332. doi: 1010.3969\/j."},{"key":"10.1016\/j.diabres.2025.112965_b0155","doi-asserted-by":"crossref","unstructured":"Li C, Zhou H, Wang P. Health utility of type 2 diabetes patients using basal insulin in China: results from the BEYOND II study. Acta Diabetologica. 2021;58:329\u201339. doi: 10.1007\/s00592-020-01618-1.","DOI":"10.1007\/s00592-020-01618-1"},{"key":"10.1016\/j.diabres.2025.112965_b0160","unstructured":"Xu L. Health-related Quality of Life among Type 2 Diabetics With and Without Complications - A Comparative Research Using EQ-5D Utility Index [Master' s thesis]. Jinan: Shandong University; 2017."},{"key":"10.1016\/j.diabres.2025.112965_b0165","unstructured":"Xu QQ, Guo XL, Chu J, Jing ZY, Zhang XY, Zhou CC. Health-related Quality of Life and Its Influencing Factors in Type 2 Diabetes Patients in Shandong Province. Journal of shandong university(health sciences). 2019;57:96\u2013103 doi: 106040\/j.issn.1671-7554.0.2018.1130."},{"key":"10.1016\/j.diabres.2025.112965_b0170","doi-asserted-by":"crossref","unstructured":"Gu S, Wang X, Shi L, Sun Q, Hu X, Gu Y, et al. Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Qual Life Res. 2020;29:2695\u2013704. doi: 10.1007\/s11136-020-02524-3.","DOI":"10.1007\/s11136-020-02524-3"},{"key":"10.1016\/j.diabres.2025.112965_b0175","unstructured":"Liu Y, Lin YT, Qi YT, Gao J, Geng XE, Cui Y, et al. Health-related Quality of Life in Patients with Type 2 Diabetes Based on the European 5-Dimensional Health Scale. J Pub Health Prev Med. 2023;34:11\u20135. doi: 10.3969\/j.issn.1006-2483.2023.04.003."},{"key":"10.1016\/j.diabres.2025.112965_b0180","unstructured":"Du HM. Moderating the Relationship of Self-empowerment and Quality-of-life among Type 2 Diabetic Patients in Shandong:the Role of Education Level [Master's degree]. Shandong: Shandong University; 2023. doi: 10.27272\/d.cnki.gshdu.2023.004238."},{"key":"10.1016\/j.diabres.2025.112965_b0185","article-title":"Medical coping style and its effects on quality of life of type 2 diabetes patients in Wuxi","volume":"32","author":"Li","year":"2019","journal-title":"Med Soc"},{"key":"10.1016\/j.diabres.2025.112965_b0190","unstructured":"Wang S. Prevalence, Risk Factors and Effects on General Quality of Life in Patients with Type 2 Diabetes Mellitus with Diabetic Retinopathy in an Urban Community [Master's degree]. Suzhou: Suzhou University; 2019. doi: 10.27351\/d.cnki.gszhu.2019.001142."},{"key":"10.1016\/j.diabres.2025.112965_b0195","first-page":"4292","article-title":"Assessment of quality of life and its related factors in patients with type 2 diabetes mellitus","volume":"38","author":"Wang","year":"2018","journal-title":"Chin J Gerontol"},{"key":"10.1016\/j.diabres.2025.112965_b0200","series-title":"Effect of measures to improve doctor's quality on blood sugar management in patients with type 2 diabetes mellitus [Master's degree]","author":"Wang","year":"2019"},{"key":"10.1016\/j.diabres.2025.112965_b0205","doi-asserted-by":"crossref","unstructured":"Kang N, Liu X, Liao W, Tu R, Sang S, Zhai Z, et al. Health-related quality of life among rural adults with type 2 diabetes mellitus: a cross-sectional study. Eur J Public Health 2021;31:547\u201353. doi: 10.1093\/eurpub\/ckaa247.","DOI":"10.1093\/eurpub\/ckaa247"},{"key":"10.1016\/j.diabres.2025.112965_b0210","unstructured":"Liu QL. Prevalence and Influencing Factors of Fear of Hypoglycemia in Hospitalized patients with Type 2 Diabetes Mellitus [Master' degree]. Urumqi: Xinjiang Medical University; 2022. doi: 10.27433\/d.cnki.gxyku.2022.000454."},{"key":"10.1016\/j.diabres.2025.112965_b0215","unstructured":"Lin P, Liu Z, Hong X, Chen X, Liu J. Evaluation and analysis of the quality of life of type 2 diabetic patients, Hainan. Modern Preventive Med 2023;50:1509\u201315. doi: 10.20043\/j.cnki.MPM.202207170."},{"key":"10.1016\/j.diabres.2025.112965_b0220","doi-asserted-by":"crossref","unstructured":"Lu Y, Wang N, Chen Y, Nie X, Li Q, Han B, et al. Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China. BMC Endocr Disord 2017;17:38. doi: 10.1186\/s12902-017-0187-1.","DOI":"10.1186\/s12902-017-0187-1"},{"key":"10.1016\/j.diabres.2025.112965_b0225","doi-asserted-by":"crossref","unstructured":"Pan CW, Wang S, Wang P, Xu CL, Song E. Diabetic retinopathy and health-related quality of life among Chinese with known type 2 diabetes mellitus. Qual Life Res 2018;27:2087\u201393. doi: 10.1007\/s11136-018-1876-6.","DOI":"10.1007\/s11136-018-1876-6"},{"key":"10.1016\/j.diabres.2025.112965_b0230","doi-asserted-by":"crossref","unstructured":"Pan CW, Sun HP, Zhou HJ, Ma Q, Xu Y, Luo N, et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med Decis Making 2016;36:234\u201341. doi: 10.1177\/0272989x15606903.","DOI":"10.1177\/0272989X15606903"},{"key":"10.1016\/j.diabres.2025.112965_b0235","doi-asserted-by":"crossref","unstructured":"Zhuang Y, Ma QH, Pan CW, Lu J. Health-related quality of life in older Chinese patients with diabetes. PLoS One 2020;15:e0229652. doi: 10.1371\/journal.pone.0229652.","DOI":"10.1371\/journal.pone.0229652"},{"key":"10.1016\/j.diabres.2025.112965_b0240","unstructured":"Ying L, Guan H, Liu G, Sun L. The influences of alcohol consumption on the life quality of patients with type 2 diabetes mellitus in China. Chinese Health Econ 2017;36:74\u20136. doi: 10.7664\/che20170621."},{"key":"10.1016\/j.diabres.2025.112965_b0245","article-title":"Evaluation of health-related quality of life in type 2 diabetic patients with various complications and oral drug treatment China","volume":"29","author":"Han","year":"2013","journal-title":"J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112965_b0250","doi-asserted-by":"crossref","unstructured":"Tang Z, Jiang X, Hong L, Feng Z, He Q, Yuan J, et al. Validation of the simplified chinese version of the brief diabetes quality of life (DQoL) questionnaire based on a cross-sectional study. Int J Environ Res Public Health 2020;17. doi: 10.3390\/ijerph17238792.","DOI":"10.3390\/ijerph17238792"},{"key":"10.1016\/j.diabres.2025.112965_b0255","doi-asserted-by":"crossref","unstructured":"Zhang Y, Sun J, Pang Z, Wang X, Gao W, Ning F, et al. The impact of new screen-detected and previously known type 2 diabetes on health-related quality of life: a population-based study in Qingdao, China. Qual Life Res. 2014;23:2319\u201326. doi: 10.1007\/s11136-014-0674-z.","DOI":"10.1007\/s11136-014-0674-z"},{"key":"10.1016\/j.diabres.2025.112965_b0260","unstructured":"Huang SG. Research on the Relationships among Fear of Hypoglycemia, Self-efficacy and Quality of Life in Patients with Type 2 Diabetes Mellitus [Master's degree]. Changchun: Jilin University; 2017."},{"key":"10.1016\/j.diabres.2025.112965_b0265","doi-asserted-by":"crossref","unstructured":"Hao S, Heintz E, Helgesson G, Langenski\u00f6ld S, Chen J, Burstr\u00f6m K. Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China. Qual Life Res 2020;29:289\u2013301. doi: 10.1007\/s11136-019-02292-9.","DOI":"10.1007\/s11136-019-02292-9"},{"key":"10.1016\/j.diabres.2025.112965_b0270","doi-asserted-by":"crossref","unstructured":"Carter N, Li J, Xu M, Li L, Fan X, Zhu S, et al. Health-related quality of life of people with type 2 diabetes and its associated factors at a tertiary care clinic in Ningbo, China: a cross-sectional study. Endocrinol Diabetes Metab 2022;5:e353. doi: 10.1002\/edm2.353.","DOI":"10.1002\/edm2.353"},{"issue":"221\u20136","key":"10.1016\/j.diabres.2025.112965_b0275","first-page":"32","article-title":"Study on health-related quality of life of patients with type 2 diabetes and its complications in Shenzhen City","volume":"39","author":"Zhao","year":"2023","journal-title":"Occup and Health"},{"key":"10.1016\/j.diabres.2025.112965_b0280","unstructured":"Su SH. Study on the current situation and related factors of fear ofhypoglycemia among elderly patients with type 2 diabetes mellitusbased on the theory of unpleasant symptoms [Master's degree]. Chengdu: Chengdu University of TCM; 2023. doi: 10.26988\/d.cnki.gcdzu.2023.000615."},{"key":"10.1016\/j.diabres.2025.112965_b0285","unstructured":"Xie K. Research on quality of life and influencing factors in patients with type 2 diabetes mellitus in China [Master's degree]. Tianjin: Tianjin University; 2014."},{"key":"10.1016\/j.diabres.2025.112965_b0290","doi-asserted-by":"crossref","unstructured":"Pan CW, Sun HP, Wang X, Ma Q, Xu Y, Luo N, et al. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Qual Life Res. 2015;24:1767\u201374. doi: 10.1007\/s11136-014-0902-6.","DOI":"10.1007\/s11136-014-0902-6"},{"key":"10.1016\/j.diabres.2025.112965_b0295","doi-asserted-by":"crossref","unstructured":"Afshari S, Ameri H, Baharinya S, Arab-Zozani M, Mojahedian MM. Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res 2022;22:351\u201364. doi: 10.1080\/14737167.2022.2011216.","DOI":"10.1080\/14737167.2022.2011216"},{"key":"10.1016\/j.diabres.2025.112965_b0300","doi-asserted-by":"crossref","unstructured":"Tao X, Xue Y, Niu R, Lu W, Yao H, He C, et al. Comparisons of clinical outcomes between newly diagnosed early- and late-onset T2DM: a real-world study from the Shanghai Hospital Link Database. Endocr Connect. 2024;13. doi: 10.1530\/ec-23-0474.","DOI":"10.1530\/EC-23-0474"},{"key":"10.1016\/j.diabres.2025.112965_b0305","doi-asserted-by":"crossref","unstructured":"Hayes A, Arima H, Woodward M, Chalmers J, Poulter N, Hamet P, et al. Changes in quality of life associated with complications of diabetes: results from the ADVANCE study. Value Health. 2016;19:36\u201341. doi: 10.1016\/j.jval.2015.10.010.","DOI":"10.1016\/j.jval.2015.10.010"},{"key":"10.1016\/j.diabres.2025.112965_b0310","doi-asserted-by":"crossref","unstructured":"Shao H, Yang S, Fonseca V, Stoecker C, Shi L. Estimating quality of life decrements due to diabetes complications in the united states: the health utility index (HUI) diabetes complication equation. Pharmacoeconomics. 2019;37:921\u20139. doi: 10.1007\/s40273-019-00775-8.","DOI":"10.1007\/s40273-019-00775-8"},{"key":"10.1016\/j.diabres.2025.112965_b0315","doi-asserted-by":"crossref","unstructured":"Kuo S, Yang C-T, Chen H-Y, Ou H-T. Valuing health states of people with type 2 diabetes: analyses of the nationwide representative linked databases. J Diab Invest 2021;12:1749\u201358. doi: 10.1111\/jdi.13520.","DOI":"10.1111\/jdi.13520"},{"key":"10.1016\/j.diabres.2025.112965_b0320","doi-asserted-by":"crossref","unstructured":"Lung TW, Hayes AJ, Hayen A, Farmer A, Clarke PM. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res 2011;20:1669\u201378. doi: 10.1007\/s11136-011-9902-y.","DOI":"10.1007\/s11136-011-9902-y"},{"key":"10.1016\/j.diabres.2025.112965_b0325","doi-asserted-by":"crossref","unstructured":"Committee ADAPP. Older adults: standards of medical care in diabetes. Diabetes Care. 2022;45:S195-s207. doi: 10.2337\/dc22-S013.","DOI":"10.2337\/dc22-S013"},{"key":"10.1016\/j.diabres.2025.112965_b0330","doi-asserted-by":"crossref","unstructured":"Takahara M, Katakami N, Shiraiwa T, Abe K, Ayame H, Ishimaru Y, et al. Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L. Acta Diabetol 2019;56:309\u201319. doi: 10.1007\/s00592-018-1244-6.","DOI":"10.1007\/s00592-018-1244-6"},{"key":"10.1016\/j.diabres.2025.112965_b0335","doi-asserted-by":"crossref","unstructured":"Bansback N, Brazier J, Tsuchiya A, Anis A. Using a discrete choice experiment to estimate health state utility values. J Health Econ 2012;31:306\u201318. doi: 10.1016\/j.jhealeco.2011.11.004.","DOI":"10.1016\/j.jhealeco.2011.11.004"},{"key":"10.1016\/j.diabres.2025.112965_b0340","doi-asserted-by":"crossref","unstructured":"Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1\u201330. 10.1016\/0167-6296(86)90020-2.","DOI":"10.1016\/0167-6296(86)90020-2"},{"key":"10.1016\/j.diabres.2025.112965_b0345","doi-asserted-by":"crossref","unstructured":"Nikl A, Janssen MF, Brodszky V, Rencz F. A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample. Health Qual Life Outcomes 2023;21:17. doi: 10.1186\/s12955-023-02096-z.","DOI":"10.1186\/s12955-023-02096-z"},{"key":"10.1016\/j.diabres.2025.112965_b0350","doi-asserted-by":"crossref","unstructured":"Sayah FA, Qiu W, Xie F, Johnson JA. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Qual Life Res 2017;26:2057\u201366. doi: 10.1007\/s11136-017-1559-8.","DOI":"10.1007\/s11136-017-1559-8"},{"key":"10.1016\/j.diabres.2025.112965_b0355","doi-asserted-by":"crossref","unstructured":"Gundle KR, Cizik AM, Punt SE, Conrad EU, 3rd, Davidson DJ. validation of the SF-6D health state utilities measure in lower extremity sarcoma. Sarcoma. 2014;2014:450902. doi: 10.1155\/2014\/450902.","DOI":"10.1155\/2014\/947082"},{"key":"10.1016\/j.diabres.2025.112965_b0360","doi-asserted-by":"crossref","unstructured":"Ye Z, Sun L, Wang Q. A head-to-head comparison of EQ-5D-5\u2009L and SF-6D in Chinese patients with low back pain. Health Qual Life Outcomes 2019;17:57. doi: 10.1186\/s12955-019-1137-6.","DOI":"10.1186\/s12955-019-1137-6"},{"key":"10.1016\/j.diabres.2025.112965_b0365","doi-asserted-by":"crossref","unstructured":"Xie S, Wang D, Wu J, Liu C, Jiang W. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey. Health Qual Life Outcomes 2022;20:96. doi: 10.1186\/s12955-022-02003-y.","DOI":"10.1186\/s12955-022-02003-y"},{"key":"10.1016\/j.diabres.2025.112965_b0370","doi-asserted-by":"crossref","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727\u201336. doi: 10.1007\/s11136-011-9903-x.","DOI":"10.1007\/s11136-011-9903-x"},{"key":"10.1016\/j.diabres.2025.112965_b0375","doi-asserted-by":"crossref","unstructured":"Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22:1717\u201327. doi: 10.1007\/s11136-012-0322-4.","DOI":"10.1007\/s11136-012-0322-4"},{"key":"10.1016\/j.diabres.2025.112965_b0380","doi-asserted-by":"crossref","unstructured":"Jiang J, Hong Y, Zhang T, Yang Z, Lin T, Liang Z, et al. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China. Qual Life Res 2021;30:2045\u201360. doi: 10.1007\/s11136-021-02786-5.","DOI":"10.1007\/s11136-021-02786-5"},{"key":"10.1016\/j.diabres.2025.112965_b0385","doi-asserted-by":"crossref","unstructured":"Weng G, Hong Y, Luo N, Mukuria C, Jiang J, Yang Z, et al. Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. Eur J Health Econ 2023;24:197\u2013207. doi: 10.1007\/s10198-022-01465-7.","DOI":"10.1007\/s10198-022-01465-7"},{"key":"10.1016\/j.diabres.2025.112965_b0390","doi-asserted-by":"crossref","unstructured":"Tai Z, Wan D, Zan Q, Huang Y, Xu C. Comparison of the EQ-5D-3L and EQ-5D-5L instruments in patients undergoing unicompartmental knee arthroplasty. Front Med (Lausanne). 2024;11:1451979. doi: 10.3389\/fmed.2024.1451979.","DOI":"10.3389\/fmed.2024.1451979"},{"key":"10.1016\/j.diabres.2025.112965_b0395","doi-asserted-by":"crossref","unstructured":"Zhao Y, Li SP, Liu L, Zhang JL, Chen G. Does the choice of tariff matter?: a comparison of EQ-5D-5L utility scores using Chinese, UK, and Japanese tariffs on patients with psoriasis vulgaris in Central South China. Medicine (Baltimore). 2017;96:e7840. doi: 10.1097\/MD.0000000000007840.","DOI":"10.1097\/MD.0000000000007840"},{"key":"10.1016\/j.diabres.2025.112965_b0400","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jval.2016.05.018","article-title":"EQ-5D scores for diabetes-related comorbidities","volume":"19","author":"Sullivan","year":"2016","journal-title":"Value Health."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725009799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725009799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:58:47Z","timestamp":1781067527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725009799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"alternative-id":["S0168822725009799"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112965","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health state utility values for patients with type 2 diabetes in China: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112965"}}